Clinical Trial Update: Gene-activated Matrix for Bone Tissue Repair in Maxillofacial Surgery [NA]

View source ↗

Summary

Clinical trial update for a gene-activated matrix designed to repair bone tissue in maxillofacial surgery; phase and status details are not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alveolar Bone Atrophy
• Benign Bone Neoplasms
• Disorders of Teeth and Jaws
• Fractures of the Mandible
• Maxillofacial Bone Defects
• Maxillofacial Deformities

Drugs mentioned

• Gene-activated Matrix for Bone Tissue Repair

Snippet

Sponsor: NextGen Company Limited | Conditions: Maxillofacial Bone Defects, Alveolar Bone Atrophy | NA | Status: UNKNOWN